XML 51 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 8 - Non-controlling Interest (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Aug. 04, 2017
Dec. 30, 2015
Apr. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Mar. 31, 2017
May 31, 2012
Payments to Noncontrolling Interests       $ 40,000    
Shares Issued, Price Per Share       $ 0.25      
Clyra [Member]              
Minority Interest Decrease From Redemption, Shares Purchased     500        
Payments to Noncontrolling Interests     $ 40,000        
Stock Issued During Period, Shares, New Issues 1,562.5            
Noncontrolling Interest, Increase from Subsidiary Equity Issuance $ 250,000            
Common Stock, Shares Owned 15,297.5            
Noncontrolling Interest, Ownership Percentage by Parent 46.30%     46.30%      
Clyra Medical Technology Inc [Member]              
Equity Method Investment, Ownership Percentage             100.00%
Preferred Stock, Dividend Rate, Percentage   8.00%          
Preferred Shares Dividend, Period   5 years          
Dividends Payable       $ 165,000      
Shares Issued, Price Per Share $ 160            
Proceeds from Issuance of Private Placement $ 1,000,000            
Stock Issued During Period, Shares, New Issues 6,250            
Clyra Medical Technology Inc [Member] | Sanatio [Member]              
Shares Issued, Price Per Share $ 160            
Stock Issued During Period, Shares, New Issues 1,690            
Clyra Medical Technology Inc [Member] | Sanatio [Member]              
Line of Credit Facility, Maximum Borrowing Capacity           $ 250,000  
Debt Instrument, Interest Rate, Stated Percentage           10.00%  
Original Issue Discount, Percentage           5.00%  
Debt Conversion, Original Debt, Amount $ 270,400            
Clyra Medical Technology Inc [Member] | Each of 3 Individuals [Member]              
Equity Method Investment, Ownership Percentage             46.30%